EMPAGLI MET 12.5MG 850MG TAB (14s)

Metformin 850mg primarily works by reducing glucose production in the liver and enhancing insulin sensitivity in peripheral tissues. It inhibits gluconeogenesis by suppressing the production of glucose in the liver, leading to lower blood glucose levels. On the other hand, Empagliflozin 12.5mg, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, blocks the reabsorption of glucose in the kidneys, promoting the excretion of glucose in urine. This dual mechanism of action helps lower blood glucose levels by reducing both hepatic glucose output and enhancing glucose elimination through the kidneys.